Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to collect long-term data on safety and
effectiveness of fingolimod, particularly including clinical disease and patient outcome
related parameters such as relapse and disability, in patients who have participated in prior
trials within the fingolimod clinical development program. Furthermore, this study explores
the incidence of selected safety related outcomes of fingolimod treatment during follow-up
visits within the context of routine medical practice.